Author pages are created from data sourced from our academic publisher partnerships and public sources.
Choosing a skeletal muscle relaxant.
Skeletal muscle relaxants are widely used in treating musculoskeletal conditions. However, evidence of their effectiveness consists mainly of studies with poor methodologic design. In addition, these… Expand
Exenatide: A Novel Incretin Mimetic Agent for Treating Type 2 Diabetes Mellitus
Maintaining glycemic control is the primary goal for preventing macrovascular and microvascular complications associated with type 2 diabetes. Currently available antidiabetic drugs work in different… Expand
Penicillin-Induced Jarisch–Herxheimer Reaction
OBJECTIVE To report a case of Jarisch–Herxheimer reaction (JHR) in a patient with presumed neurosyphilis and HIV. CASE SUMMARY A 45-year-old HIV-positive man (CD4+ count 450 cells/mm3 and history of… Expand
Trimethoprim/Sulfamethoxazole—Induced Toxic Epidermal Necrolysis
OBJECTIVE: To report a case of toxic epidermal necrolysis (TEN) associated with trimethoprim/sulfamethoxazole (TMP/SMX). CASE SUMMARY: A 34-year-old Asian woman developed a severe, desquamating… Expand
Skeletal Muscle Relaxants
Health care providers prescribe skeletal muscle relaxants for a variety of indications. However, the comparative efficacy of these drugs is not well known. Skeletal muscle relaxants consist of both… Expand
Akathisia Induced by Gabapentin Withdrawal
OBJECTIVE: To report a case of akathisia in a patient with type 2 diabetes after abrupt discontinuation of gabapentin. CASE SUMMARY: A 76-year-old female with type 2 diabetes was admitted for change… Expand
Angiotensin II receptor blockers for the treatment of hypertension
- S. See
- Expert opinion on pharmacotherapy
- 1 November 2001
The rising incidence of stroke, congestive heart failure (CHF) and end stage renal disease (ESRD) has signalled a need to increase awareness, treatment and control of hypertension. There continues to… Expand
Digoxin increases mortality among women with congestive heart failure.
Digoxin increases mortality in women with congestive heart failure, compared with men; however, the clinical significance of this is unknown since gender is a nonmodifiable risk factor. More… Expand
Implementation of a Symptom-Triggered Benzodiazepine Protocol for Alcohol Withdrawal in Family Medicine Inpatients
Purpose The purpose of this pilot study was to review the implementation of symptom-triggered benzodiazepine therapy and evaluate the feasibility and outcomes as compared with a previous hospital… Expand